Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : Bmy    crawled date : 2021 - 04 - 15    save search

Ikena Oncology Appoints Dr. Maria Koehler to its Board of Directors
Published: 2021-04-15 (Crawled : 13:00) - biospace.com/
BMY | $48.93 1.3% 0.0% 10M twitter stocktwits trandingview |
Health Technology
| | O: 0.3% H: 1.14% C: 0.69%
RPTX 4 | $3.14 3.97% 3.82% 220K twitter stocktwits trandingview |
Health Technology
| | O: 0.67% H: 1.74% C: -1.22%
BCYC | $23.41 -4.41% -4.61% 550K twitter stocktwits trandingview |
Health Technology
| | O: 1.1% H: 1.45% C: -1.06%


Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cabometyx® (cabozantinib) as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma
Published: 2021-04-14 (Crawled : 00:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 1.09% C: 0.35%
BMY | $48.93 1.3% 0.0% 10M twitter stocktwits trandingview |
Health Technology
| | O: 0.27% H: 0.33% C: 0.09%
EXEL | $22.51 0.09% 0.09% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.38% H: 4.2% C: 3.09%

treatment europe renal approval cell carcinoma nivolumab
Gainers vs Losers
67% 33%

Top 10 Gainers

Your saved searches
Save your searches and get alerts when important news are released.